SURGERY PARTNERS INC (SGRY)

US86881A1007 - Common Stock

23.35  +0.84 (+3.73%)

After market: 23.49 +0.14 (+0.6%)

Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to SGRY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 37.93. This target is 62.44% above the current price.
SGRY was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about SGRY.
In the previous month the buy percentage consensus was at a similar level.
SGRY was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 23.3531.3136.2137.9352.50 - 34.09% 55.07% 62.44% 124.84%
Up and Down Grades
Date Firm Action Rating
2024-11-20 RBC Capital Maintains Outperform -> Outperform
2024-11-19 Macquarie Maintains Outperform -> Outperform
2024-11-13 Macquarie Maintains Outperform -> Outperform
2024-11-04 Macquarie Maintains Outperform -> Outperform
2024-10-14 UBS Initiate Buy
2024-10-11 Keybanc Initiate Sector Weight
2024-10-04 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-26 Benchmark Reiterate Buy -> Buy
2024-08-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-19 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-07 RBC Capital Reiterate Outperform -> Outperform
2024-08-07 Benchmark Reiterate Buy -> Buy
2024-08-07 Citigroup Maintains Buy -> Buy
2024-07-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-02 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-28 Macquarie Initiate Outperform
2024-05-08 Citigroup Maintains Buy -> Buy
2024-05-01 Benchmark Reiterate Buy -> Buy
2024-04-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-06 Barclays Initiate Equal-Weight
2024-03-05 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-02-29 RBC Capital Reiterate Outperform -> Outperform
2024-02-27 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-02-27 Citigroup Maintains Buy -> Buy
2023-11-14 TD Cowen Upgrade Market Perform -> Outperform
2023-10-12 Benchmark Reiterate Buy -> Buy
2023-09-14 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-02 Benchmark Reiterate Buy -> Buy
2023-08-02 Barclays Maintains Overweight -> Overweight